Lifevantage Corporation (NASDAQ:LFVN)

Wednesday, May 7, 2025 | Web News
LifeVantage Corporation (NASDAQ:LFVN) ($11.97; $150.2M market cap) announced Q3 2025 results: Q3 sales of...
Tuesday, March 4, 2025 | Web News
Lifevantage Corporation (NASDAQ:LFVN) ($16.82; $216.5 M market cap) announced the launch of the Evolve Compensation plan into the Philippines,...
Thursday, February 6, 2025 | Web News
Lifevantage Corporation (NASDAQ:LFVN) ($22.74; $284.8 M market cap) (currently marked down ~20% pre market) announced Q2...
See All Research...
Friday, July 26, 2024, 9:17 AM
GLP-1 Natural Weight Loss Therapy Gives LFVN A Life Line
See All Articles and Reports...
Sunday, February 8, 2026, 3:27 PM
Two Stocks To Consider Amid The Software Carnage, Reinforced By Our Conversations With Ben Brostoff And Special Situation Investor, John Cormier [GeoWire Weekly No. 225] | FRTN ATGN KINS CAWW LFVN ASYS NURS.V CZZL.NE
Sunday, December 21, 2025, 3:28 PM
Skull Session with a Revenue-Based Financing Company; Run to $1.00 Model Portfolio Heating Up [GeoWire Weekly No. 218] | 🇺🇸 PXHI LRGR CITR ATGN 🇨🇦 BDT.TO
Sunday, November 23, 2025, 3:29 PM
Tecogen Partnership Update with Vertiv, Another Skull Session with Biorem CEO, Weekly Earnings Highlights [GeoWire Weekly No. 214] | FSI KTEL TGEN BRM.V INX.V COV.V
See All GeoWire Weekly...

LifeVantage maker of Protandim®, the Nrf2 Synergizer™ patented dietary supplement, is a science based nutraceutical company. LifeVantage is dedicated to visionary science that looks to transform wellness and anti-aging internally and externally with products that dramatically reduce oxidative stress at the cellular level.

Web site: http:// www.LifeVantage.com

Last updated June 6, 2008


Market Data powered by QuoteMedia. Terms of Use